PKC activity in rat C6 glioma cells: changes associated with cell cycle and simvastatin treatment.
The parallel effects of simvastatin on cell cycle and PKC activity in rat C6 glioma cells were investigated. Simvastatin, 2.5 microM, for 24 h resulted in cell growth arrest in early G1 phase of the cell cycle and in a significant increase of total PKC activity (283 +/- 42 vs 470 +/- 61 pmoles/min/mg protein p = 0.002 for control cells and simvastatin-treated cells, respectively). The effect of simvastatin was fully prevented by mevalonate. A time dependent increase of PKC activity was observed in control exponentially free-growing C6 cells approaching confluency: a highly significant negative correlation (r = -0.91 p < 0.0001) between PKC activity and growth rate was calculated. PKC activity was high in cells arrested in G0 by serum starvation (0.4%). Following addition of complete medium (17.5% serum) the PKC activity progressively decreased and reached a minimum when cells traversed the G2/M phase, as determined by DNA analysis distribution. PKC activity dropped 30% in simvastatin-arrested early G1 cells; 44% in hydroxyurea-arrested cells at the G1/S boundary; and 73% in Colcemid mitosis-blocked cells. The results show that C6 glioma cell PKC activity is maximal in a G0 quiescent state and varies at different points of the cell cycle.
Soma
M R
MR
Institute of Pharmacological Sciences, University of Milan, Italy.
Baetta
R
R
Bergamaschi
S
S
De Renzis
M R
MR
Davegna
C
C
Battaini
F
F
Fumagalli
R
R
Govoni
S
S
D000818:Animals; D001254:Astrocytoma / Q000201:enzymology / Q000473:pathology; D002453:Cell Cycle / Q000187:drug effects; D003703:Demecolcine / Q000494:pharmacology; D005910:Glioma / Q000201:enzymology* / Q000473:pathology; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006918:Hydroxyurea / Q000494:pharmacology; D008148:Lovastatin / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008798:Mevalonic Acid / Q000494:pharmacology; D011493:Protein Kinase C / Q000378:metabolism*; D051381:Rats; D019821:Simvastatin; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000201:enzymology / Q000473:pathology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008148:Lovastatin; D019821:Simvastatin; D011493:Protein Kinase C; D008798:Mevalonic Acid; D006918:Hydroxyurea; D003703:Demecolcine